Trading Ideas

Looking to trade with more confidence? Giles Coghlan shares expert analysis to help you spot opportunities and navigate risks in equities, forex, and commodities.

His clear, actionable outlooks are trusted by traders worldwide and featured in Reuters, WSJ, Business Insider, FT Adviser, NBC, and more.

Stay ahead with insights that cut through the noise – from one of the industry’s most respected analysts.

Is Bayer a buy?

Bayer AG shares surged higher on Tuesday this week on news that the German company forecast its peak sale of pharmaceuticals to €12 billion. Bayer forecast that its thrombosis treatment asundexian could bring in more than €5 billion. Revenue from…

Read MoreIs Bayer a buy?